期刊论文

中文

中成药

1001-1528

2022

44

3

780-784

10.3969/j.issn.1001-1528.2022.03.017

湖南省中医药管理局重点项目（201820）； 湖南省教育厅科研项目（19B437）；

本校为第一机构

目的探讨中风Ⅱ号方联合常规治疗对缺血性脑卒中气虚血瘀证患者的临床疗效。方法100例患者随机分为对照组和观察组,每组50例,对照组给予常规治疗(阿司匹林、阿托伐他汀、苯磺酸左氨氯地平等),观察组在对照组基础上加用中风Ⅱ号方,疗程7 d。检测临床疗效、ESS评分、中医证候评分、病残/致死程度、NSE、NGF、D-D、Ang-1变化,再对NSE、D-D、Ang-1与ESS评分、中医证候评分进行相关性分析。结果观察组总有效率高于对照组(P

AIM To explore the clinical effects of Stroke NO.Ⅱ Decoction combined with conventional treatment on patients with ischemic stroke due to Qi Deficiency and Blood Stasis. METHODS One hundred patients were randomly assigned into control group(50 cases) for 7-day intervention of conventional treatment(aspirin, atorvastatin, levamlodipine besylate, etc.), and observation group(50 cases) for 7-day intervention of both Stroke NO.Ⅱ Decoction and conventional treatment. The changes in clinical efficacy, ESS score, TCM syndrome scores, disability/mort...